FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121116603> ?p ?o ?g. }

• W2121116603 endingPage "242" @default.
• W2121116603 startingPage "233" @default.
• W2121116603 abstract "The majority of p53 mutations, which are responsible for gain of oncogenic function, are missense mutations in hotspot codons. However, in our previous study, we demonstrated that a deletion spanning codons 127-133 in the p53 gene (designated as del p53) was detected in doxorubicin-resistant MCF-7 cell lines following various induction processes. In the present study, we aimed to investigate the role of del p53 and its association with the proliferation, metastasis and drug resistance of MCF-7 cells. The MCF-7/del p53 cell line is a representative of the del p53 stably expressed clones which were constructed by transfection of the del p53-containing construct into MCF-7/wt cells. Markers of multidrug resistance (MDR), epithelial-mesenchymal transition (EMT) and stem cell-like properties were examined in the MCF-7/del p53 cells. The results revealed that the MCF-7/del p53 cells expressed full-length p53 and del p53 mRNA and protein, as well as P-glycoprotein (P-gp). The MCF-7/del p53 cells acquired resistance to doxorubicin with increased P-gp efflux function. Using a transient expression assay, the mdr1 promoter was found to be significantly activated by external or integrated del p53 (P<0.001). The inhibition of nuclear factor (NF)-κB by cyclosporine sensitized the MCF-7/del p53 cells to doxorubicin toxicity. In addition, the morphological characteristics of the MCF-7/del p53 and MCF-7/adr were similar. EMT was observed in the MCF-7/del p53 cells as demonstrated by the presence of the mesenchymal markers, Slug and vimentin, and the decrease in the epithelial marker, cadherin 1, type 1, E-cadherin (CDH1), as well as an enhanced migration ability (P<0.001). Furthermore, the number of cells expressing the cancer stem cell-like marker, CD44, increased, accompanied by mammosphere formation. Taken together, these findings indicate that the expression of del p53 in MCF-7/del p53 cells enables the cells to partially acquire doxorubicin resistance characteristics of the MCF-7/adr cells. Thus, del p53 may be an important factor in non-invasive MCF-7 cells, activating NF-κB signaling and the mdr1 promoter and partially attributing to EMT; the cells thus acquire stem cell‑like properties, which facilitates drug resistance. Therefore, the 21-bp deletion of p53 may prove to be a therapeutic strategy with which to prevent cancer cells from acquiring resistance to drugs." @default.
• W2121116603 created "2016-06-24" @default.
• W2121116603 creator A5015242729 @default.
• W2121116603 creator A5028836589 @default.
• W2121116603 creator A5035605618 @default.
• W2121116603 creator A5051101817 @default.
• W2121116603 creator A5083937797 @default.
• W2121116603 date "2015-11-11" @default.
• W2121116603 modified "2023-10-15" @default.
• W2121116603 title "Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells" @default.
• W2121116603 cites W1484483530 @default.
• W2121116603 cites W1572599368 @default.
• W2121116603 cites W1965822047 @default.
• W2121116603 cites W1976731794 @default.
• W2121116603 cites W1983173409 @default.
• W2121116603 cites W1987912339 @default.
• W2121116603 cites W1988214676 @default.
• W2121116603 cites W1993075625 @default.
• W2121116603 cites W2001953597 @default.
• W2121116603 cites W2002376765 @default.
• W2121116603 cites W2002573912 @default.
• W2121116603 cites W2005852730 @default.
• W2121116603 cites W2009156222 @default.
• W2121116603 cites W2011069301 @default.
• W2121116603 cites W2027032958 @default.
• W2121116603 cites W2033413353 @default.
• W2121116603 cites W2033826636 @default.
• W2121116603 cites W2040006344 @default.
• W2121116603 cites W2042484101 @default.
• W2121116603 cites W2043620899 @default.
• W2121116603 cites W2046847797 @default.
• W2121116603 cites W2047172303 @default.
• W2121116603 cites W2050569275 @default.
• W2121116603 cites W2055393036 @default.
• W2121116603 cites W2058268469 @default.
• W2121116603 cites W2059399555 @default.
• W2121116603 cites W2065629669 @default.
• W2121116603 cites W2071107415 @default.
• W2121116603 cites W2076149108 @default.
• W2121116603 cites W2078836749 @default.
• W2121116603 cites W2080392221 @default.
• W2121116603 cites W2081894694 @default.
• W2121116603 cites W2084831115 @default.
• W2121116603 cites W2085744313 @default.
• W2121116603 cites W2088245792 @default.
• W2121116603 cites W2093932304 @default.
• W2121116603 cites W2097255042 @default.
• W2121116603 cites W2097420405 @default.
• W2121116603 cites W2101382252 @default.
• W2121116603 cites W2114906733 @default.
• W2121116603 cites W2115659663 @default.
• W2121116603 cites W2126888470 @default.
• W2121116603 cites W2129201741 @default.
• W2121116603 cites W2131994307 @default.
• W2121116603 cites W2136029503 @default.
• W2121116603 cites W2139151018 @default.
• W2121116603 cites W2139959086 @default.
• W2121116603 cites W2146869799 @default.
• W2121116603 cites W2147587303 @default.
• W2121116603 cites W2151837372 @default.
• W2121116603 cites W2159825798 @default.
• W2121116603 cites W2165250332 @default.
• W2121116603 cites W263274652 @default.
• W2121116603 doi "https://doi.org/10.3892/ijmm.2015.2406" @default.
• W2121116603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26572087" @default.
• W2121116603 hasPublicationYear "2015" @default.
• W2121116603 type Work @default.
• W2121116603 sameAs 2121116603 @default.
• W2121116603 citedByCount "13" @default.
• W2121116603 countsByYear W21211166032017 @default.
• W2121116603 countsByYear W21211166032018 @default.
• W2121116603 countsByYear W21211166032019 @default.
• W2121116603 countsByYear W21211166032020 @default.
• W2121116603 countsByYear W21211166032021 @default.
• W2121116603 countsByYear W21211166032022 @default.
• W2121116603 countsByYear W21211166032023 @default.
• W2121116603 crossrefType "journal-article" @default.
• W2121116603 hasAuthorship W2121116603A5015242729 @default.
• W2121116603 hasAuthorship W2121116603A5028836589 @default.
• W2121116603 hasAuthorship W2121116603A5035605618 @default.
• W2121116603 hasAuthorship W2121116603A5051101817 @default.
• W2121116603 hasAuthorship W2121116603A5083937797 @default.
• W2121116603 hasBestOaLocation W21211166031 @default.
• W2121116603 hasConcept C104317684 @default.
• W2121116603 hasConcept C109541995 @default.
• W2121116603 hasConcept C114851261 @default.
• W2121116603 hasConcept C121608353 @default.
• W2121116603 hasConcept C127561419 @default.
• W2121116603 hasConcept C133936738 @default.
• W2121116603 hasConcept C143065580 @default.
• W2121116603 hasConcept C153911025 @default.
• W2121116603 hasConcept C190283241 @default.
• W2121116603 hasConcept C2776694085 @default.
• W2121116603 hasConcept C2778707650 @default.
• W2121116603 hasConcept C2781303535 @default.
• W2121116603 hasConcept C29537977 @default.
• W2121116603 hasConcept C2994423619 @default.
• W2121116603 hasConcept C502942594 @default.

• next